Forskning om IMT

– Sidan under uppbyggnad –

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.


Forskare

Dr. Cheryl M. Coffin
Dr. Jason L. Hornick.
Dr. Christopher D. Fletcher.
Dr. Tomoaki Kato
Dr. Carola A. Arndt
Dr. Sabine Sarnacki
Dr. Christopher Moir


Tidskrifter

Journal of Clinical Pathology
Informa Healthcare
The Doctors Doctor
Journal of Cancer Research and Therapeutics
World Journal of Surgical Oncology
American Journal of Roentgenology

Video


7-Year-Old Girl Has 6 Organs Removed For Inoperable Abdominal Tumor Surgery

Artiklar


Stanford School of Medicine Diagnostic Criteria 

The New England Journal of Medicine 2010:Oct 20, Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor

http://www.onkologiisverige.se/virtupload/onkologi/content/28/ALK.pdf 

Atlas of Genetics and Cytogenetics in Oncology and Hematology

Case Report – Splenic Inflammatory Pseudotumor (Inflammatory Myofibroblastic Tumor) [PDF]

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor

Inflammatory myofibroblastic tumor in children: clinical review 

Inflammatory Myofibroblastic Tumors in Childhood 

Girl recovering after removal of 6 organs, tumor

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer 

A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalisation. Promotes Apoptosis and Inhibits Cancer Growth 

ALK Fusion 

Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation

Uterine Inflammatory Myofibroblastic Tumor in a 10-Year-Old Girl Presenting As Polypoid Mass

An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor 

http://www.cancer.gov/cancertopics/druginfo/fda-crizotinib  (0m Crizotinib)

Cancer Treatment: Crizotinib 

ALK inblandad i många cancerformer. Onkologi i Sverige s. 70-78 

Inflammatory myofibroblastic tumor

Retroperitoneal inflammatory myofibroblastic tumor: A case report 

Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum 

Inflammatory myofibroblastic tumors of the pancreas in children

Inflammatory Myo broblastic Tumor of the Stomach: A Rare Case Report in a 10-Year-Old Girl 

A clinical and genomic profile of inflammatory myofibroblastic tumors

Crizotinib in Pediatric ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors 

Successful Treatment of Recurrent Pediatric Inflammatory Myofibroblastic Tumor in a Single Patient With a Novel Chemotherapeutic Regimen Containing Celecoxib